These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1085785)

  • 1. A simple method for screening human T and B lymphocyte alloantibodies.
    Hsia S; Ward FE; Amos DB
    J Immunol Methods; 1976; 12(3-4):337-43. PubMed ID: 1085785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of B-cell-specific alloantibodies in pregnancy sera in the lymphocytotoxicity and the indirect immunofluorescence techniques.
    Décary F; van Helden-Henningheim L; van Griethuysen D; Helmerhorst FM; van der Werf AJ; Engelfriet CP
    Tissue Antigens; 1979 Jul; 14(1):1-9. PubMed ID: 91215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Differences in the capacity of HLA sera to react with T- and B-lymphocyte populations].
    Zotikov EA; Tananov AT
    Biull Eksp Biol Med; 1976 Jun; 81(6):698-9. PubMed ID: 60152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of complement-fixing and non-fixing antibodies specific for endothelial precursor cells and lymphocytes using flow cytometry.
    AlMahri A; Holgersson J; Alheim M
    Tissue Antigens; 2012 Nov; 80(5):404-15. PubMed ID: 22931381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dilutions and specificity analysis of pretransplant sera.
    Iwaki Y; Terasaki PI; Park MS; Heintz R; Silberman H; Berne T
    Transplant Proc; 1979 Mar; 11(1):944-9. PubMed ID: 377726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [C4d]FlowPRA screening--a specific assay for selective detection of complement-activating anti-HLA alloantibodies.
    Wahrmann M; Exner M; Haidbauer B; Schillinger M; Regele H; Körmöczi G; Böhmig GA
    Hum Immunol; 2005 May; 66(5):526-34. PubMed ID: 15935890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies of the antibodies against HLA, Ia-like, Fc, and/or C3 receptors present in pretransplant sera: anti-B-cell antibodies not associated with accelerated graft loss.
    Soulillou JP; Peyrat MA; Guenel J
    Transplant Proc; 1978 Jun; 10(2):475-7. PubMed ID: 354139
    [No Abstract]   [Full Text] [Related]  

  • 8. Specific inhibition of T-cell-mediated cytolosis by alloantiserum against HLA-D-related (DR) antigens.
    Feighery CF; Stastny P
    Transplant Proc; 1979 Mar; 11(1):708-11. PubMed ID: 88098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of protease-digested human peripheral blood lymphocytes for the detection of lymphocyte-reactive alloantibodies by indirect immunofluorescence.
    Lobo PI; Winfield JB; Craig A; Westervelt FB
    Transplantation; 1977 Jan; 23(1):16-21. PubMed ID: 319572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serological inhibition of blast transformation to purified streptococcal antigens by planned immunization in HLA (A,B) compatible unrelated individuals.
    Greenberg LJ; Chopky RL; Noreen H; Gray ED; Yunis EJ; Ferrara GB
    Vox Sang; 1978; 34(3):136-42. PubMed ID: 414452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human lymphocyte dependent antibody mediated cytotoxicity: adherence of lymphocytes to antibody treated target cells.
    Yust I; Smith RW; Dickler HB; Wunderlich J; Mann DL
    Cell Immunol; 1975 Jul; 18(1):176-86. PubMed ID: 1079753
    [No Abstract]   [Full Text] [Related]  

  • 12. Production of specific antisera to human B lymphocytes.
    Goodfellow P; Barnstable C; Jones E; Bodmer WF; Crumpton MJ; Snary D
    Tissue Antigens; 1976 Feb; 7(2):105-17. PubMed ID: 775683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alloantibodies to PHA-activated lymphocytes detect human Qa-like antigens.
    Gazit E; Gothelf Y; Gil R; Orgad S; Pitman TB; Watson AL; Yang SY; Yunis EJ
    J Immunol; 1984 Jan; 132(1):165-9. PubMed ID: 6606664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A rapid solid-phase rosette-inhibition assay for the detection of Fc receptor (FcRII)-blocking alloantibodies [corrected].
    Hadley AG; Leader K; Laundy G; Smith A; Klouda P; Bradley BA
    Immunol Lett; 1991 Mar; 27(3):215-20. PubMed ID: 2060973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA antibodies cytotoxic only for B lymphocytes.
    Richiardi P; Diotallevi P; Matejc T; Carbonara AO; Curtoni ES
    Tissue Antigens; 1977 Oct; 10(4):323-9. PubMed ID: 72430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alloantibodies that react with subsets of human T cells.
    van Leeuwen A
    Tissue Antigens; 1979 Nov; 14(5):437-43. PubMed ID: 12731575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of autologous and allogeneic human T cells by B cells occurs through separate B-cell antigen systems.
    Smith JB
    Cell Immunol; 1978 Mar; 36(2):203-9. PubMed ID: 147135
    [No Abstract]   [Full Text] [Related]  

  • 18. Human T lymphocyte differentiation antigens.
    Touraine JL
    Isr J Med Sci; 1975 Dec; 11(12):1348-56. PubMed ID: 56326
    [No Abstract]   [Full Text] [Related]  

  • 19. Surface markers on human b and t lymphocytes. VI. Cytotoxicity against cell lines as a functional marker for lymphocyte subpopulations.
    Jondal M; Pross H
    Int J Cancer; 1975 Apr; 15(4):596-605. PubMed ID: 806545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions of Fc receptors with antibodies against Ia antigens and other cell surface components.
    Schirrmacher V; Halloran P; David CS
    J Exp Med; 1975 May; 141(5):1201-9. PubMed ID: 1079233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.